One of our hardest critics raised the target I'm re sharing a story from comment below. Zacks raised target from strong sell to a hold. The consensus on Aphria is 16.50 usd roughly. Unlike investors, they don't take into consideration Aphria and Tilrays merger and further potential. They want to see quarterly results first and we as investors want to be invested before all the good news breaks. That's what investing is all about making the right calls before the world catch's on. Even if the consensus price on Aphria were right (it's not, we're worth minimum 28 USD time will prove it) that would mean Aphria would fall less then a dollar if it aligned with some of its critics. We shook out the paper hands and if this ain't buy what is in this market? Nio may be a good buy too know doubt there if you're looking to diversify sectors a bit. If people wait to see quarterly reports and news that can spring at any moment like Irwin Simon and Tilray have been doing then you will be sorta late on the train. Know the company now believe and invest.
https://www.marketbeat.com/instant-alerts/nasdaq-apha-consensus-analyst-rating-2021-03-2-3/?fbclid=IwAR0ibh7gkelWgCmgRPT9dj4yYesLcH-H32dRH5_bejydVfK_huXm6nwxOJU